Drug Pipeline

Galcanezumab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03432286 A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic… Episodic Migraine Active, Not Recruiting
NCT04616326 A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic… Chronic Migraine Active, Not Recruiting
Early Phase 1
NCT07323927 Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease Alzheimer Disease Recruiting
Sponsors Running Galcanezumab Trials
Eli Lilly and Company (2) Xuanwu Hospital, Beijing (1)
Disease Areas
Migraine (2) Alzheimer's Disease (1)
Get alerts when Galcanezumab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free